Influence of intensive multifunctional neurorehabilitation on neuronal oxidative damage in patients with Huntington's disease

被引：0

作者：

Ciancarelli, Irene ^{[1
,2
]}

De Amicis, Daniela ^{[1
]}

Di Massimo, Caterina ^{[1
]}

Sandrini, Giorgio ^{[3
]}

Pistarini, Caterina ^{[4
,5
]}

Carolei, Antonio ^{[1
]}

Ciancarelli, Maria Giuliana Tozzi ^{[1
]}

机构：

[1] Univ Aquila, Dept Med Hlth & Environm Sci, I-67100 Laquila, Italy

[2] Nova Salus Rehabil & Nursing Home, Laquila, Italy

[3] C Mondino Natl Neurol Inst, Neurorehabil Unit, Pavia, Italy

[4] Salvatore Maugeri Fdn, Spinal Unit, Dept Neurorehabil, Pavia, Italy

[5] Salvatore Maugeri Fdn, Spinal Unit, Dept Coma, Pavia, Italy

来源：

FUNCTIONAL NEUROLOGY | 2015年 / 30卷 / 01期

关键词：

Cu/Zn-superoxide dismutase; Huntington's disease; neuron-specific enolase; neurorehabilitation; oxidative stress; 8-hydroxy-2-deoxyguanosine;

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The influence of intensive multifunctional neurorehabilitation on serum levels of Cu/Zn-superoxide dismutase (Cu/Zn-SOD), neuron-specific enolase (NSE), and 8-hydroxy-2-deoxyguanosine (8-OHdG), as markers of oxidative damage, was evaluated in symptomatic patients with Huntington's disease (HD). Improved clinical outcome measures were observed after neurorehabilitation. Baseline levels of Cu/Zn-SOD, NSE and 8-OHdG were higher than those observed in controls. Cu/Zn-SOD and NSE values decreased after neurorehabilitation, but were still higher than those measured in controls. Cu/Zn-SOD and NSE correlated positively before (r=0.659; p=0.003) and after rehabilitation (r=0.553, p=0.017). 8-OHdG values decreased after neurorehabilitation without reaching significance when compared with baseline values (p=0.145). No correlation was observed between the measured oxidative markers and the assessed clinical outcome measures, either before or after neurorehabilitation. The findings reported in the present paper provide evidence of the effectiveness of neurorehabilitation in reducing oxidative damage in HD patients and underline the limit of serum oxidative markers for the evaluation of clinical features of HD.

引用

页码：47 / 52

页数：6

共 40 条

[1] Effect of endurance exercise training on the expression of GFAP, S100B, and NSE in the striatum of chronic/progressive mouse model of Parkinson's disease [J].

Al-Jarrah, Muhammed D. ;

Jamous, Mohammed .

NEUROREHABILITATION, 2011, 28 (04) :359-363

[2] THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE [J].

ANDREW, SE ;

GOLDBERG, YP ;

KREMER, B ;

TELENIUS, H ;

THEILMANN, J ;

ADAM, S ;

STARR, E ;

SQUITIERI, F ;

LIN, BY ;

KALCHMAN, MA ;

GRAHAM, RK ;

HAYDEN, MR .

NATURE GENETICS, 1993, 4 (04) :398-403

[3]

Arida RM, 2013, CURR PHARM DESIGN, V19, P6720

[4] Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease Report of the Guideline Development Subcommittee of the American Academy of Neurology [J].

Armstrong, Melissa J. ;

Miyasaki, Janis M. .

NEUROLOGY, 2012, 79 (06) :597-603

[5] Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease [J].

Aziz, N. A. ;

Jurgens, C. K. ;

Landwehrmeyer, G. B. ;

van Roon-Mom, W. M. C. ;

van Ommen, G. J. B. ;

Stijnen, T. ;

Roos, R. A. C. ;

Orth, M. ;

Handley, O. J. ;

Schwenke, C. ;

Ho, A. ;

Wild, E. J. ;

Tabrizi, S. J. ;

Landwehrmeyer, G. B. ;

Bachoud-Levi, A-C ;

Bentivoglio, A. R. ;

Biunno, I. ;

Bonelli, R. ;

Burgunder, J-M ;

Dunnett, S. B. ;

Ferreira, J. J. ;

Handley, O. J. ;

Heiberg, A. ;

Illman, T. ;

Levey, J. ;

Nielsen, J. E. ;

Paivarinta, M. ;

Roos, R. A. C. ;

Sebastian, A. Rojo ;

Tabrizi, S. J. ;

Vandenberghe, W. ;

Verellen-Dumoulin, C. ;

Zaremba, J. ;

Uhrova, T. ;

Wahlstrom, J. ;

Wallner, M. ;

Barth, K. ;

Garde, M. Bascunana ;

Bos, R. ;

Ecker, D. ;

Handley, O. J. ;

Heinonen, N. ;

Held, C. ;

Laura, M. ;

Descals, A. Martinez ;

Mestre, T. ;

Monza, D. ;

Naji, J. ;

Padieu, H. ;

Koivisto, S. Pro .

NEUROLOGY, 2009, 73 (16) :1280-1285

[6] Effectiveness of physiotherapy, occupational therapy, and speech pathology for people with Huntington's disease: A systematic review [J].

Bilney, B ;

Morris, ME ;

Perry, A .

NEUROREHABILITATION AND NEURAL REPAIR, 2003, 17 (01) :12-24

[7] Physical therapy in Huntington's disease - toward objective assessments? [J].

Bohlen, S. ;

Ekwall, C. ;

Hellstrom, K. ;

Vesterlin, H. ;

Bjornefur, M. ;

Wiklund, L. ;

Reilmann, R. .

EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (02) :389-393

[8] 8OHdG is not a biomarker for Huntington disease state or progression [J].

Borowsky, Beth ;

Warner, John ;

Leavitt, Blair R. ;

Tabrizi, Sarah J. ;

Roos, Raymund A. C. ;

Durr, Alexandra ;

Becker, Chris ;

Sampaio, Cristina ;

Tobin, Allan J. ;

Schulman, Howard .

NEUROLOGY, 2013, 80 (21) :1934-1941

[9] Physical therapy intervention for people with Huntington disease [J].

Busse, Monica E. ;

Khalil, Hanan ;

Quinn, Lori ;

Rosser, Anne E. .

PHYSICAL THERAPY, 2008, 88 (07) :820-831

[10] Does exercise reduce brain oxidative stress? A systematic review [J].

Camiletti-Moiron, D. ;

Aparicio, V. A. ;

Aranda, P. ;

Radak, Z. .

SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2013, 23 (04) :e202-e212

← 1 2 3 4 →